Topics:

Insurance companies thwart uptake of Merck's Gardasil in boys

May 8, 2014 | By
Tools

Use of Merck's ($MRK) HPV jab Gardasil among boys has been growing since the CDC expanded its recommendation in 2011 to include both genders. But some insurance companies have put up roadblocks, labeling the vaccine--which can cost up to $500 for three doses--"experimental" for boys. Story | More

Filed Under
,

Comments

Press Releases
  • Ginkgo Bioworks To Purchase 100 Million Base Pairs Of Synthetic DNA From Twist Bioscience To Meet Growing Customer Demand For Biological Manufacturing
  • Genomics England Selects Cognizant as a Technology Partner for the Department of Health's 100,000 Genomes Project
  • Medrobotics Closes $25 Million Financing
  • Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke
  • Agenus to Acquire Antibody Manufacturing Capability, Expands Antibody Discovery and adds Cell Line Development Capabilities with Three Separate Transactions
  • More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.